These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 29464896)

  • 1. Corticostriatal network dysfunction in Huntington's disease: Deficits in neural processing, glutamate transport, and ascorbate release.
    Rebec GV
    CNS Neurosci Ther; 2018 Apr; 24(4):281-291. PubMed ID: 29464896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulation of corticostriatal ascorbate release and glutamate uptake in transgenic models of Huntington's disease.
    Rebec GV
    Antioxid Redox Signal; 2013 Dec; 19(17):2115-28. PubMed ID: 23642110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticostriatal dysfunction underlies diminished striatal ascorbate release in the R6/2 mouse model of Huntington's disease.
    Dorner JL; Miller BR; Klein EL; Murphy-Nakhnikian A; Andrews RL; Barton SJ; Rebec GV
    Brain Res; 2009 Sep; 1290():111-20. PubMed ID: 19616518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysregulation of Corticostriatal Connectivity in Huntington's Disease: A Role for Dopamine Modulation.
    Rangel-Barajas C; Rebec GV
    J Huntingtons Dis; 2016 Dec; 5(4):303-331. PubMed ID: 27983564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington's disease.
    Cepeda C; Hurst RS; Calvert CR; Hernández-Echeagaray E; Nguyen OK; Jocoy E; Christian LJ; Ariano MA; Levine MS
    J Neurosci; 2003 Feb; 23(3):961-9. PubMed ID: 12574425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired development of cortico-striatal synaptic connectivity in a cell culture model of Huntington's disease.
    Buren C; Parsons MP; Smith-Dijak A; Raymond LA
    Neurobiol Dis; 2016 Mar; 87():80-90. PubMed ID: 26711622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential electrophysiological and morphological alterations of thalamostriatal and corticostriatal projections in the R6/2 mouse model of Huntington's disease.
    Parievsky A; Moore C; Kamdjou T; Cepeda C; Meshul CK; Levine MS
    Neurobiol Dis; 2017 Dec; 108():29-44. PubMed ID: 28757327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysfunctional Calcium and Glutamate Signaling in Striatal Astrocytes from Huntington's Disease Model Mice.
    Jiang R; Diaz-Castro B; Looger LL; Khakh BS
    J Neurosci; 2016 Mar; 36(12):3453-70. PubMed ID: 27013675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulation of ascorbate release in the striatum of behaving mice expressing the Huntington's disease gene.
    Rebec GV; Barton SJ; Ennis MD
    J Neurosci; 2002 Jan; 22(2):RC202. PubMed ID: 11784814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of GLT1 reverses the deficit in cortically evoked striatal ascorbate efflux in the R6/2 mouse model of Huntington's disease.
    Miller BR; Dorner JL; Bunner KD; Gaither TW; Klein EL; Barton SJ; Rebec GV
    J Neurochem; 2012 May; 121(4):629-38. PubMed ID: 22332910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysfunctional behavioral modulation of corticostriatal communication in the R6/2 mouse model of Huntington's disease.
    Hong SL; Cossyleon D; Hussain WA; Walker LJ; Barton SJ; Rebec GV
    PLoS One; 2012; 7(10):e47026. PubMed ID: 23056565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The corticostriatal pathway in Huntington's disease.
    Cepeda C; Wu N; André VM; Cummings DM; Levine MS
    Prog Neurobiol; 2007 Apr; 81(5-6):253-71. PubMed ID: 17169479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of mutant huntingtin in cortical efferents improves behavioral inflexibility and corticostriatal dynamics in Huntington's disease mice.
    Estrada-Sánchez AM; Blake CL; Barton SJ; Howe AG; Rebec GV
    J Neurophysiol; 2019 Dec; 122(6):2621-2629. PubMed ID: 31693428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single Synapse Indicators of Impaired Glutamate Clearance Derived from Fast iGlu
    Dvorzhak A; Helassa N; Török K; Schmitz D; Grantyn R
    J Neurosci; 2019 May; 39(20):3970-3982. PubMed ID: 30819797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disrupted striatal neuron inputs and outputs in Huntington's disease.
    Reiner A; Deng YP
    CNS Neurosci Ther; 2018 Apr; 24(4):250-280. PubMed ID: 29582587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticostriatal dysfunction and glutamate transporter 1 (GLT1) in Huntington's disease: interactions between neurons and astrocytes.
    Estrada-Sánchez AM; Rebec GV
    Basal Ganglia; 2012 Jul; 2(2):57-66. PubMed ID: 22905336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticostriatal Dysfunction in Huntington's Disease: The Basics.
    Bunner KD; Rebec GV
    Front Hum Neurosci; 2016; 10():317. PubMed ID: 27445757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperactive striatal neurons in symptomatic Huntington R6/2 mice: variations with behavioral state and repeated ascorbate treatment.
    Rebec GV; Conroy SK; Barton SJ
    Neuroscience; 2006; 137(1):327-36. PubMed ID: 16257492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential changes in thalamic and cortical excitatory synapses onto striatal spiny projection neurons in a Huntington disease mouse model.
    Kolodziejczyk K; Raymond LA
    Neurobiol Dis; 2016 Feb; 86():62-74. PubMed ID: 26621114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulated Neuronal Activity Patterns Implicate Corticostriatal Circuit Dysfunction in Multiple Rodent Models of Huntington's Disease.
    Miller BR; Walker AG; Barton SJ; Rebec GV
    Front Syst Neurosci; 2011; 5():26. PubMed ID: 21629717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.